AKTS
AKTS
NASDAQ · Biotechnology

Aktis Oncology Inc

$24.93
+1.14 (+4.79%)
As of Aug 14, 8:40 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price in Context
52-Week High
$34.19
-27.1% from high
52-Week Low
$14.72
+69.4% from low
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%